Daniel McCormack

628 total citations
47 papers, 409 citations indexed

About

Daniel McCormack is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Daniel McCormack has authored 47 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Public Health, Environmental and Occupational Health, 18 papers in Epidemiology and 8 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Daniel McCormack's work include Opioid Use Disorder Treatment (18 papers), HIV, Drug Use, Sexual Risk (8 papers) and Substance Abuse Treatment and Outcomes (7 papers). Daniel McCormack is often cited by papers focused on Opioid Use Disorder Treatment (18 papers), HIV, Drug Use, Sexual Risk (8 papers) and Substance Abuse Treatment and Outcomes (7 papers). Daniel McCormack collaborates with scholars based in Canada, Ireland and United States. Daniel McCormack's co-authors include Tara Gomes, Tony Antoniou, Gillian Kolla, Sophie A. Kitchen, Mina Tadrous, David Mulcahy, Peter C. Austin, Tonya Campbell, Angela Jerath and Duminda N. Wijeysundera and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Daniel McCormack

44 papers receiving 394 citations

Peers

Daniel McCormack
Shernaz S. Dossabhoy United States
Margarita Burmester United Kingdom
Ashley L. Miller United States
Brooke Kenney United States
John M. VanBuren United States
Aamir Bharmal Canada
Ruiying Xiong United States
Brian M. Clemency United States
Frédérique Claudot France
Michael Neeki United States
Shernaz S. Dossabhoy United States
Daniel McCormack
Citations per year, relative to Daniel McCormack Daniel McCormack (= 1×) peers Shernaz S. Dossabhoy

Countries citing papers authored by Daniel McCormack

Since Specialization
Citations

This map shows the geographic impact of Daniel McCormack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel McCormack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel McCormack more than expected).

Fields of papers citing papers by Daniel McCormack

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel McCormack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel McCormack. The network helps show where Daniel McCormack may publish in the future.

Co-authorship network of co-authors of Daniel McCormack

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel McCormack. A scholar is included among the top collaborators of Daniel McCormack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel McCormack. Daniel McCormack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gomes, Tara, Daniel McCormack, Gillian Kolla, et al.. (2025). Comparing the effects of prescribed safer opioid supply and methadone in Ontario, Canada: a population-based matched cohort study. The Lancet Public Health. 10(5). e412–e421. 2 indexed citations
2.
3.
Antoniou, Tony, Kathleen Pajer, William Gardner, et al.. (2024). Impact of COVID-19 pandemic on prescription stimulant use among children and youth: a population-based study. European Child & Adolescent Psychiatry. 33(8). 2669–2680. 2 indexed citations
4.
5.
Tadrous, Mina, et al.. (2024). Trends in opioid toxicities among people with and without opioid use disorder and the impact of the COVID-19 pandemic in Ontario, Canada: A population-based analysis. International Journal of Drug Policy. 127. 104392–104392. 3 indexed citations
6.
MacDonald, Martha, et al.. (2023). Trends in varying modes of drug use in opioid toxicity deaths in Ontario from 2017 to 2021. International Journal of Drug Policy. 141. 104197–104197. 7 indexed citations
7.
Tadrous, Mina, Daniel McCormack, Tonya Campbell, et al.. (2023). Assessing the impact of the slow-release oral morphine drug shortages in Ontario, Canada: A population-based time series analysis. International Journal of Drug Policy. 118. 104119–104119. 1 indexed citations
8.
Hu, Tina, Daniel McCormack, David N. Juurlink, et al.. (2023). Initiation of opioid agonist therapy after hospital visits for opioid poisonings in Ontario. Canadian Medical Association Journal. 195(49). E1709–E1717. 6 indexed citations
9.
Antoniou, Tony, Daniel McCormack, Deshayne B. Fell, Jeffrey C. Kwong, & Tara Gomes. (2023). Impact of national recommendations for routine pertussis vaccination during pregnancy on infant pertussis in Ontario, Canada: a population-based time-series study. BMC Pregnancy and Childbirth. 23(1). 627–627. 3 indexed citations
10.
Young, Samantha, Tara Gomes, Gillian Kolla, et al.. (2023). Initiations of safer supply hydromorphone increased during the COVID-19 pandemic in Ontario: An interrupted time series analysis. PLoS ONE. 18(12). e0295145–e0295145. 4 indexed citations
11.
Antoniou, Tony, Daniel McCormack, Kathleen Pajer, et al.. (2023). Geographic variation and sociodemographic correlates of prescription psychotropic drug use among children and youth in Ontario, Canada: a population-based study. BMC Public Health. 23(1). 85–85. 3 indexed citations
12.
Gomes, Tara, et al.. (2022). Clinical outcomes and health care costs among people entering a safer opioid supply program in Ontario. Canadian Medical Association Journal. 194(36). E1233–E1242. 57 indexed citations
13.
Young, Samantha, Gillian Kolla, Daniel McCormack, et al.. (2022). Characterizing safer supply prescribing of immediate release hydromorphone for individuals with opioid use disorder across Ontario, Canada. International Journal of Drug Policy. 102. 103601–103601. 36 indexed citations
14.
McCormack, Daniel, et al.. (2022). Impact of the COVID-19 Controlled Drugs and Substances Act exemption on pharmacist prescribing of opioids, benzodiazepines and stimulants in Ontario: A cross-sectional time-series analysis. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 155(6). 326–333. 3 indexed citations
15.
McCormack, Daniel, et al.. (2022). Regional differences in access to direct-acting antiviral treatments for hepatitis C across Ontario: A cross-sectional study. SHILAP Revista de lepidopterología. 48(4). 170–178. 3 indexed citations
16.
Antoniou, Tony, Daniel McCormack, Tonya Campbell, et al.. (2020). Geographic variation in the provision of naloxone by pharmacies in Ontario, Canada: A population-based small area variation analysis. Drug and Alcohol Dependence. 216. 108238–108238. 10 indexed citations
17.
Guilcher, Sara J. T., Mary‐Ellen Hogan, Daniel McCormack, et al.. (2020). Prescription medications dispensed following a nontraumatic spinal cord dysfunction: a retrospective population-based study in Ontario, Canada. Spinal Cord. 59(2). 132–140. 14 indexed citations
18.
McCormack, Daniel, Xiao‐Mei Mai, & Yue Chen. (2015). Determinants of vitamin D supplement use in Canadians. Public Health Nutrition. 20(10). 1768–1774. 7 indexed citations
19.
McCormack, Daniel, et al.. (2006). RETROSPECTIVE REVIEW OF LATE PRESENTING DDH IN IRELAND FOR 2004.. 268–268. 1 indexed citations
20.
Devitt, Aiden, et al.. (1998). Patellofemoral contact forces and pressures during intramedullary tibial nailing. International Orthopaedics. 22(2). 92–96. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shernaz S. Dossabhoy Breakdown of academic impact, for papers by Margarita Burmester Breakdown of academic impact, for papers by Ashley L. Miller Breakdown of academic impact, for papers by Brooke Kenney Breakdown of academic impact, for papers by John M. VanBuren Breakdown of academic impact, for papers by Aamir Bharmal Breakdown of academic impact, for papers by Ruiying Xiong Breakdown of academic impact, for papers by Brian M. Clemency Breakdown of academic impact, for papers by Frédérique Claudot Breakdown of academic impact, for papers by Michael Neeki
Rankless by CCL
2026